Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents

European Journal of Medicinal Chemistry

Volumn 40, Issue 9, 2005, Pages 949-959

  Rida, Samia M ^a   Ashour, Fawzia A ^a   El Hawash, Soad A M ^a   ElSemary, Mona M ^a   Badr, Mona H ^a   Shalaby, Manal A ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Universities and Research centers District   (Egypt)

Author keywords

2 (2,3 Dihydrothiazol 5 yl)benzoxazoles; 2 Arylidenecynomethylbenzoxazoles; 2 Cynomethylbenzoxazole; 2 Hydrazonocynomethylbenzoxazoles; 2 Thiocarbamoylcyanomethylbenzoxazoles; 3H pyrido 2,1 b benzoxazoles; Anti HIV 1; Anticancer; Antimicrobial activity

Indexed keywords

2 (4 OXOTHIAZOLIDIN 2 YLIDENE)METHYLBENZOXAZOLE; 2 [(3 HYDROXY 4 METHOXYBENZYLIDENE)CYANOMETHYL]BENZOXAZOLE; 2 [(CYCLOHEXYLIDENE)CYANOMETHYL]BENZOXAZOLE; AMPICILLIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BENZOXAZOLE DERIVATIVE; COTRIMOXAZOLE; ETHYL (4 CYANO 1 OXO 1H PYRIDO[2,1 B]BENZOXAZOLE) 2 CARBOXYLATE; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANDIDA ALBICANS; CELL PROTECTION; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; BENZOXAZOLES; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 25444483572     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2005.03.023     Document Type: Article

References (40)

1. C.T. Bahner, L.M. Rives, S.W. McGaha, D. Rutledge, D. Ford, E. Gooch, D. Westberry, D. Ziegler, and R. Ziegler Arzneim.- Forsch. 31 3 1981 404 406
2. M. Ueki, K. Ueno, S. Miyadoh, K. Abe, K. Shibata, M. Taniguchi, and S.J. Oi Antibiot. 46(7) (1993) 1089-94 Chem. Abstr. 120 1994 49669k
3. C.C. Cheng, D.E. Liu, and T.C. Chou Heterocycles 35(2) (1993) 775 Chem. Abstr. 120 1994 217507b
4. D. Shi, T.D. Bradshaw, S. Wrigley, C.J. McCall, P. Lelieveld, I. Fichtner, and M.F.G. Stevens J. Med. Chem. 39 1996 3375 3384
5. I.H. Hall, N.J. Peaty, J.R. Henry, J. Easmon, G. Heinisch, and G. Purshinger Arch. Pharm. (Weinheim) 332 4 1999 115 123
6. D.D. Kumar, R. Jacob, B. Renolds, and M. Kerwin Bioorg. Med. Chem. 10 12 2002 3997 4004
7. J. Easmon, G. Puerstinger, T. Roth, H.H. Fiebg, M. Jenny, G. Heinisch, and J. Hofmann Int. J. Cancer 94 1 2001 89 96
8. K.H. Michel, L.D. Boeck, M.M. Hoehn, N.D. Jones, and M.O. Chaney J. Antibiot. 37 5 1984 441 445 Chem. Abstr. 101 (1984) 108873e.
9. S.K. Balani, S.M. Pitzenberger, L.R. Kauffman, B.H. Arison, H.G. Ramjit, M.E. Goldman, J.A. O'Brien, J.D. King, J.M. Hoffman, C.S. Rooney, and A.D. Theoharides Drug Metab. Dispos. 20 6 1992 869 875
10. J.M. Hoffman, A.M. Smith, C.S. Rooney, T.E. Fisher, J.S. Wai, C.M. Thomas, D.L. Bamberger, J.L. Barnes, T.M. Williams, J.H. Jones, B.D. Olson, J.A. O'Brien, M.E. Goldman, J.H. Nunberg, J.C. Quintero, W.A. Schleif, E.A. Emini, and P.S. Anderson J. Med. Chem. 36 1993 953 966
11. W.S. Saari, J.S. Wai, T.E. Fisher, C.M. Thomas, J.M. Hoffman, C.S. Rooney, A.M. Smith, J.H. Jones, D.L. Bamberger, M.E. Goldman, J.A. O'Brien, J.H. Nunberg, J.C. Quintero, W.A. Schleif, E.A. Emini, and P.S. Anderson J. Med. Chem. 35 1992 3792 3802
12. L. Perrin, A. Rakik, S. Yearly, C. Baumberger, S. Kinloch-de Loies, M. Pechiere, and B. Hirschel AIDS 10 1996 1233 1237
13. S. Staszewski, F.E. Massari, A. Kaber, R. Gohler, S. Durrr, K.W. Anderson, C.L. Schneider, J.A. Waterbury, K.K. Bakshi, V.I. Taylor, C.S. Hildebrand, C. Kriesl, B. Haffstedt, W.A. Schleif, and V.W. Byrnes J. Infect. Dis. 171 1995 1159 1165
14. D.B. Olsen, S.S. Carroll, J.C. Culberson, J.A. Shafer, and L.C. Kuo Nucleic Acids Res. 22 1994 1437 1443
15. M. Prudhomme, J. Guyat, and G. Jeminet J. Antibiotics 39 1986 934 937
16. T. Arpaci, I. Oeren, and N. Altanlar IL Farmaco 57 3 2002 175 182
17. T. Arpaci, A. Sener, I. Yalcin, and N. Altanlar Arch. Pharm.(WeinHeim) 335 6 2002 283 288
18. T. Arpaci, A. Sener, I. Yalcin, and N. Altanlar IL Farmaco 57 9 2002 771 775
19. S. Ersan, S. Nacak, R. Berkem, and T. Ozden Arzneim.-, Forsch. 47 8 1997 963
20. I. Oren, O. Temiz, I. Yalcin, E. Sener, A. Akin, and N. Ucarturk Arzneim.-, Forsch. 47 12 1997 1393 1397
21. O. Temiz, I. Oren, E. Sener, and N. Ucarturk Il Farmaco 53 1998 337
22. E. Sener, I. Yalcin, O. Temiz, I. Oren, A. Akin, and N. Ucarturk Il Farmaco 52 2 1997 99 103
23. I. Yalcin, I. Oren, A. Akin, and N. Ucarturk Eur. J. Med. Chem. 27 1992 401 406
24. R. Reiner Antibiotic 1982 Georg Thiem Verlag Stuttgart-New York 107
25. J.E.F. Reynold Martindale, The Extra Pharmacopoeia 29th ed., Part 1 (1989) The Pharmaceutical Press London 147
26. P.K. Gupta, S. Daunert, M.R. Nassiri, L.L. Worthing, J.C. Drash, and L.B. Townsend J. Med. Chem. 32 1989 402
27. L.A. Mitschers D.A. Williams T.L. Lemke Antibiotic and Antimicrobial Agents in Foy's Principles of Medicinal Chemistry 2002 Lippinctt Williams and Wilkins Philadelphia 849 fifth ed.
28. S.M. Rida, N.S. Habib, E.A.M. Badawey, H.T.Y. Fahmy, and H.A. Ghozlan Arch. Pharm. (Weinheim) 328 1995 325
29. M.H. Elnagdi, M.A. Khalifa, M.K. Ibraheim, and M.R. Elmoghayar J. Heterocycl. Chem. 18 1981 877
30. L. Bukowski, M. Janowiec, Z. Zwolska-Kwiek, and Z. Andrzejczyk Pharmazie 53 1998 373
31. E.A.M. Badawey, A.A. Hazzaa, S.M. Rida, and H.T.Y. Fahmy Arch. Pharm. (Weinheim) 325 1992 565
32. E.A.M. Badawey, S.M. Rida, F.S.G. Soliman, and T. Kappe J. Heterocyclic Chem. 20 1989 73
33. S.M. Rida, F.S.G. Soliman, and E.A.M. Badawey J. Heterocyclic Chem. 25 1988 1725
34. S.A. Osman, G.H. Egemeie, G.A. Nawar, and M.M. Sallam J. Heterocyclic Chem. 21 1984 1885
35. S.M. Rida, N.S. Habib, S.M. Rida, H.T.Y. Fahmy, and H.A. Gozlan Arch. Pharm. (Weinheim) 328 1995 325
36. M. Grever, S. Schepartz, and B. Chabner The National Cancer Institute Cancer Drug Discovery and Development Program, Semin Oncol. 19 1992 622
37. M. Boyed, and K. Paull Drug Dev. Res. 34 1995 91
38. O.W. Weislow, R. Kiser, D. Fine, J. Bader, R.H. Shoemaker, and M.R. Boyd J. Natl. Cancer Inst. 81 1989 577
39. J.E. Conte, and S.L. Barriere Manual of Antibiotics and Infectious Diseases, first ed (1988) Lea and Febiger USA 135
40. National Committee for Clinical Laboratory Standards 1990 M7-A2, Villanova, PA USA